Some patients who take dopamine drugs to steady their movements suddenly develop compulsive gambling, a condition called dopamine dysregulation syndrome. This episode uses that puzzle to take apart the idea that dopamine is the pleasure chemical. It explains motivational salience, which marks an outcome as worth chasing or avoiding, how the D1 and D2 receptor families can excite or inhibit a neuron, and how the brain builds its own dopamine from phenylalanine, tyrosine, and L-DOPA because dopamine itself cannot cross the blood brain barrier. About 400,000 neurons out of roughly 86 billion make it.

From there the episode follows the pathway from the substantia nigra that sets the action threshold for movement and fails in Parkinson’s disease, and the reward circuit from the ventral tegmental area. It covers how cocaine blocks dopamine transporters, why stimulants help ADHD by raising activity in the prefrontal cortex, and why antipsychotics block D2 receptors. Outside the brain, dopamine widens blood vessels, increases sodium excretion in the kidneys, and is given by IV for shock. It was first synthesized in London in 1910, and Arvid Carlsson’s 1958 work earned a Nobel Prize in 2000.

• Why L-DOPA can unlock movement and also overstimulate reward pathways
• How some amphetamines reverse transporters and dump stored dopamine
• Kathleen Montagu’s 1957 identification of dopamine in the brain
• Dopamine’s effects on insulin, gut motility, and immune cells
• The dopamine derived melanin behind butterfly wing patterns and caterpillar stripes